UnknownNot Applicable

Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women

55,497 participantsStarted 2017-01

Plain-language summary

This clinical study aims to investigate the anti-HPA antibodies caused neonatal alloimmune thrombocytopenia in Chinese pregnant women. The survey and data collect will help form an appropriate clinical screening procedure

Who can participate

Age range18 Years – 50 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 12-28 weeks pregnant Chinese women * between Jan 1, 2017 and Dec 31, 2018 Exclusion Criteria: * Not willing to participate in this study * Plan to terminate pregnancy early

What they're measuring

The positive rate of anti-HPA antibody

Timeframe: Up to one and a half years after the study completed

The morbidity of NAIT

Timeframe: Up to one and a half years after the study completed

Trial details

NCT IDNCT02934906

SponsorXinqiao Hospital of Chongqing

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-12

Contact for this trial

Li Chen

0118615178936688 chenli200401@163.com

View on ClinicalTrials.gov More Neonatal Alloimmune Thrombocytopenia trials